Arbor Biotechnologies' CEO Devyn Smith, Ph.D., Elected as Chairman of the Alliance for Regenerative Medicine
globenewswire.com
news
2022-10-20 00:00:00

CAMBRIDGE, Mass., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, a biotechnology company discovering and developing the next generation of genetic medicines, today announced that its Chief Executive Officer, Devyn Smith, Ph.D., has been elected as the Chairman of the Alliance for Regenerative Medicine (ARM), the leading international advocacy organization dedicated to realizing the promise of regenerative medicines and advanced therapies. His appointment is effective as of January 1, 2023.
